ニュース
The National Institute of Mental Health and the National Institute on Minority Health and Health Disparities lost the most ...
Columbia University and New York-Presbyterian Hospital will pay $750 million to settle hundreds of sexual abuse claims ...
The FDA approved ustekinumab-aekn (Selarsdi) injection as an interchangeable biosimilar to Stelara for the treatment of Crohn ...
The question on many minds among FDA rank-and-file in attendance was: Which Prasad would show up? The 2010s Prasad -- a ...
"It doesn't have to be perceived as an act of charity -- you take data and you use data to guide your decision making," said ...
Minor papilla endoscopic sphincterotomy did not reduce the risk of acute pancreatitis in patients with acute recurrent ...
The pressure on physicians to see more patients per hour varies by specialty and practice setting. Let's start with which ...
Columbia University and NewYork-Presbyterian Hospital agreed to pay $750 million to settle hundreds of sexual abuse claims ...
Therapy should include either belimumab or a calcineurin inhibitor, plus one or more conventional medications such as ...
Using language that's more inclusive of lesbian, gay, bisexual, transgender, queer/questioning, and more (LGBTQ+) patient populations may help improve the patient-clinician relationship and make data ...
Obicetrapib provided dramatic reductions in LDL cholesterol, without noticeable side effects, in a phase III trial of ...
The partnership will focus first on "enabling research around the root causes" of autism spectrum disorder (ASD), HHS said.
現在アクセス不可の可能性がある結果が表示されています。
アクセス不可の結果を非表示にする